Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, March 12, 2025

Intensive Versus Conservative Blood Pressure Target After Thrombectomy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

 Still no blood pressure management protocol. Hope your doctor GUESSES CORRECTLY after your stroke. 

Intensive Versus Conservative Blood Pressure Target After Thrombectomy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Stroke: Vascular and Interventional Neurology
  • INTRODUCTION

    The optimal blood pressure (BP) management following endovascular thrombectomy (EVT) for acute ischemic stroke remains unclear. The balance between maintaining adequate cerebral blood flow and preventing reperfusion injury requires the need of an evidence‐based decision. Recently, 4 randomized controlled trials (RCTs) focusing on post‐EVT BP goals were published, showing significantly lower functional independence in the intensive BP target groups. However, 2 of these trials were prematurely terminated, which may have limited the assessment of important secondary outcomes. Therefore, we performed a meta‐analysis of RCTs comparing intensive versus conservative BP target for patients following EVT after acute ischemic stroke.

    METHODS

    We conducted a meta‐analysis according to the Cochrane Collaboration Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis Statement (Supplemental Methods 1). This meta‐analysis protocol was registered at the International Prospective Register of Systematic Reviews (CRD42023473691). We systematically searched PubMed, Embase, Cochrane, and ClinicalTrials.gov from inception to October 2023. Studies were eligible if they (1) were RCTs; (2) enrolled patients with acute ischemic stroke undergoing EVT; and (3) compared intensive versus conservative BP target. The inclusion and exclusion criteria of each study are detailed in Supplemental Methods 2. Our end points were (1) a modified Rankin scale score (0–2); (2) 24‐hour National Institutes of Health Stroke Scale score; (3) 3‐month EuroQoL (Quality of Life)‐5‐Dimension‐3‐Level score; (4) all‐cause mortality; and (5) symptomatic intracranial hemorrhage within 36 hours. We evaluated the risk of bias of included RCTs with the Risk of Bias Tool. We conducted a trial sequential analysis for all‐cause mortality.
    We used restricted maximum likelihood random‐effects model with risk ratios and 95% CIs for binary end points and mean differences or standardized mean difference for continuous end points. Heterogeneity was assessed using Cochrane's Q statistic and Higgins and Thompson's I2 statistic. P value <0.05 was considered statistically significant. We used R version 4.3.1 and trial sequential analysis version 0.9.5.10 beta for statistical analysis.

    RESULTS

    Our systematic search yielded 1249 potential articles, of which 4 RCTs met inclusion criteria.1, 2, 3, 4 A total of 1565 patients were included, of whom 764 (48.8%) were randomized to intensive BP target. The mean 24‐hour SBP after EVT varied from 120.8 to 129.2 mmHg in the intensive BP target group, and from 129.5 to 139 mmHg in the conservative BP target group.
    Functional independence after 90 days was significantly less frequent with intensive BP target compared with the conservative group (risk ratio 0.80 [95% CI, 0.71–0.90]; I2 = 10%; P<0.01; Figure 1A). An intensive BP target resulted in a lower 3‐month EuroQoL (quality of life)‐5‐Dimension 3‐Level scores (standardized mean difference −0.24 [95% CI, −0.37 to −0.12]; I2 = 0%; P<0.01; Figure 1B). There were no significant differences in 24‐hour National Institutes of Health Stroke Scale score (mean difference 0.93 [95% CI, −0.36 to 2.22]; I2 = 48%; P = 0.16; Figure 1C), all‐cause mortality (risk ratio 1.15 [95% CI, 0.90–1.48]; I2 = 0%; P = 0.26; Figure 1D), and symptomatic intracranial hemorrhage within 36 hours (risk ratio 1.13 [95% CI, 0.78–1.63]; I2 = 0%; P = 0.52; Figure 1E). Risk of Bias Tool 2 identified all studies as low risk of bias. The z‐curve did not cross the required information size, conventional, and monitoring boundaries. In addition, the inner wedge is not reached. These findings suggest that more studies are needed to confirm our results (Supplemental Figure 3).
    image
    Figure 1. Meta‐analysis of intensive versus conservative blood pressure target after thrombectomy. Intensive blood pressure (BP) target is associated with (A) a reduced likelihood of achieving mRS 0–2 at 90 days and (B) lower 3‐month EQ‐5D‐3L scores, as compared with conservative BP target. However, there was no significant difference between groups in terms of (C) 24‐hour NIHSS scores, (D) all‐cause mortality, and (E) sICH within 36 hours. BEST‐II indicates Blood Pressure After Endovascular Stroke Therapy‐II; BP‐TARGET, Safety and Efficacy of Intensive Blood Pressure Lowering After Successful Endovascular Therapy in Acute Ischaemic Stroke; ENCHANTED 2/MT, Second Enhanced Control of Hypertension and Thrombectomy Stroke Study/Mechanical Thrombectomy; EQ‐5D‐3L, EuroQuality of Life‐5‐Dimension 3‐Level; IV, inverse variance; MH, Mantel‐Haenszel; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; OPTIMAL‐BP, Outcome in Patients Treated With Intraarterial Thrombectomy–Optimal Blood Pressure Control; RR, risk ratio; and sICH, symptomatic intracranial hemorrhage.

    DISCUSSION

    Our study found no differences in either all‐cause mortality or symptomatic intracranial hemorrhage between groups. This is consistent with the individual results of the 4 included RCTs, suggesting a high probability of neutrality between both strategies in these outcomes. However, functional independence (modified Rankin scale score 0–2) was 23% more frequent in the conservative as compared to the intensive group. Furthermore, the SBP <140 mm Hg goal was associated with reduced quality of life score.

    No comments:

    Post a Comment